New drug doubles one-year survival in pancreatic cancer trial
April 14, 2026
Phase 2 randomized trial shows 38% reduction in risk of death with the drug when combined with chemotherapy
Phase 2 randomized trial shows 38% reduction in risk of death with the drug when combined with chemotherapy
A major multi-site clinical trial co-led by researchers at Washington University School of Medicine in St. Louis has shown that post-thrombotic syndrome—a common and often painful complication suffered by many people who have experienced blockages of major veins due to blood clots—can be effectively treated with a minimally invasive procedure.
A Korean research team has developed a low-frequency-based wireless sensor technology.
ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
Used with Beckman’s immunoassay analysers, MeMed’s BV test has been demonstrated to reduce unnecessary antibiotic use.
Learn how an isolated but collaborative bird species shows that close social contact can shape our gut microbes in surprising ways.
Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability
Modular Medical (Nasdaq:MODD) announced today that it received FDA 510(k) clearance for its next-generation insulin patch pump.
CorTec’s BCI aims to differentiate itself by offering brain-based communication alongside therapeutic neurostimulation.
Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid diagnosis and risk assessment of cardiac injury are therefore essential for improving patient outcomes.